Although it is tempting to start patients on higher doses, especially if their body mass index is >35 kg/m2, starting with lower doses and ascertaining the patient’s responsiveness to insulin is prudent to avoid hypoglycemia [21]. This evidence concerns the gene INS and Hypoglycemia.